TITLE

Green Tea Consumption and Hematologic Malignancies in Japan

AUTHOR(S)
Naganuma, Toru; Kuriyama, Shinichi; Kakizaki, Masako; Sone, Toshimasa; Nakaya, Naoki; Ohmori-Matsuda, Kaori; Hozawa, Atsushi; Nishino, Yoshikazu; Tsuji, Ichiro
PUB. DATE
September 2009
SOURCE
American Journal of Epidemiology;Sep2009, Vol. 170 Issue 6, p730
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Several biologic studies have reported that green tea constituents have antitumor effects on hematologic malignancies. However, the effects in humans are uncertain. The authors used data from the Ohsaki National Health Insurance Cohort Study in Japan to evaluate the association between green tea consumption and the risk of hematologic malignancies. Study participants were 41,761 Japanese adults aged 40–79 years without a history of cancer at baseline who answered a food frequency questionnaire survey in 1994. During 9 years of follow-up beginning in 1995, the authors documented 157 hematologic malignancies, including 119 cases of lymphoid neoplasms and 36 cases of myeloid neoplasms. Hazard ratios were calculated by using the Cox proportional hazards regression model. Risk of hematologic malignancies was inversely associated with green tea consumption. The multivariate-adjusted hazard ratio of hematologic malignancies for 5 cups/day or more compared with less than 1 cup/day of green tea was 0.58 (95% confidence interval: 0.37, 0.89). The corresponding risk estimate was 0.52 (95% confidence interval: 0.31, 0.87) for lymphoid neoplasms and 0.76 (95% confidence interval: 0.32, 1.78) for myeloid neoplasms. This inverse association was consistent across sex and body mass index strata. In conclusion, green tea consumption was associated with a lower risk of hematologic malignancies.
ACCESSION #
44356159

 

Related Articles

  • coming your way.  // Pulse;3/19/2005, Vol. 65 Issue 11, p9 

    Presents several studies related to medical care in Great Britain. Risk involved in healthy drinking; Influence of eczema cream to increase the risk of cancer; Potential of green tea to provide anti-cancer characteristics.

  • Green Tea and Cancer Prevention in Humans: A Review. Tariq, Raseen; Hina, Sahrish // Journal of Pakistan Medical Students;Apr-Jun2013, Vol. 3 Issue 2, p63 

    Epidemiological studies have been inconsistent in finding a protective association of green tea with risk of different cancers. We conducted an extensive literature review to assess the current evidence examining the association of green tea consumption with different types of cancers. In...

  • CHEMOPREVENTION OF HUMAN PROSTATE CANCER BY ORAL ADMINISTRATION OF GREEN TEA CATECHINS: A TRANSLATIONAL RESEARCH STORY. BETTUZZI, S.; RIZZI, F. // Bulletin of the University of Agricultural Sciences & Veterinary;2008, Vol. 65 Issue 1, p29 

    This article discusses a study of the chemoprevention of prostate cancer by oral administration of green tea catechins (GTC). The study's authors conducted a Phase II, placebo-controlled clinical trial to assess the efficacy of GTC in the prevention of prostate cancer progression. They showed...

  • Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced Inflammation. Ying-Ting Lin; Yu-Hsuan Wu; Chin-Kai Tseng; Chun-Kuang Lin; Wei-Chun Chen; Yao-Chin Hsu; Jin-Ching Lee // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Chronic hepatitis C virus (HCV) infection is the leading risk factor for hepatocellular carcinoma (HCC) and chronic liver disease worldwide. Green tea, in addition to being consumed as a healthy beverage, contains phenolic catechins that have been used as medicinal substances. In the present...

  • A cup of green tea a day may keep cancer away. Charles, Dan // New Scientist;9/14/91, Vol. 131 Issue 1786, p17 

    Reports on the results of studies into the anticancer properties of green tea in Japan and the U.S. Exposure of mice to various cancer-inducing treatments; Reduction of skin cancers resulting from exposure to ultraviolet radiation; Epigallocatechin gallate.

  • NEOPLASMS.  // MPR - Residents' Edition;Spring/Summer2009, Vol. 18 Issue 1, p168 

    The article offers information on the prescription of drugs used to treat neoplasms. It states that anticancer drugs are classified as extremely toxic and potent substances and dosing should only be made with full cooperations from the involved specialist to treat a patient. Meanwhile, it also...

  • Combination of Anti-EGFR Drugs with Anti-Angiogenic or Other Signal Transduction Inhibitors as a Rational Approach to Cancer Therapy. Morelli, Maria Pia; Spratlin, Jennifer; Eckhardt, S. Gail // Current Cancer Therapy Reviews;2007, Vol. 3 Issue 4, p284 

    Activation of the epidermal growth factor receptor (EGFR)-dependent intracellular signaling pathway has a relevant role in the development and the progression of several human cancers. However, EGFR-targeted therapies have a significant clinical activity only in a subgroup of cancer patients...

  • Darbepoetin alfa not associated with increased risk for death in 2,100--patient study. Harris, Jason // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p47 

    The article discusses research on the risk for death or disease progression in patients with chemotherapy-induced anemia receiving the erythropoiesis-stimulating agent darbepoetin alfa, that references studies by H. Ludwig published in a 2009 issue of the "Journal of Clinical Oncology" and J....

  • Green Tea May Slash Breast Cancer Risk.  // Spa Management;Dec2009, Vol. 19 Issue 12, p45 

    The article discusses research being done on green tea and breast cancer. It references a study by Martha J. Shrubsole et al, published in a February 2009 issue of "Journal of Nutrition." The researchers studied women with breast cancer aged 20 to 74. The subjects were interviewed about their...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics